Nicholas J. Singer - Dec 2, 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role: Director
Signature: /s/ Nicholas J. Singer
Stock symbol: ERNA
Transactions as of: Dec 2, 2022
Transactions value $: $1,000,000
Form type: 4
Date filed: 12/6/2022, 05:52 PM
Previous filing: Aug 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERNA	Common Stock	Purchase	$232K	+70.8K	+138.87%	$3.28	122K	Dec 2, 2022	By Purchase Capital LLC	F1
transaction	ERNA	Common Stock	Purchase	$697K	+212K	+395.28%	$3.28	266K	Dec 2, 2022	By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Warrants (right to buy)	Purchase	$17.7K	+142K		$0.13^*	142K	Dec 2, 2022	Common Stock, par value $0.005 per share	142K	$3.28	By Purchase Capital LLC	F1
transaction	ERNA	Warrants (right to buy)	Purchase	$53.1K	+425K		$0.13^*	425K	Dec 2, 2022	Common Stock, par value $0.005 per share	425K	$3.28	By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.

Content

The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.